CFI-402257

CAS No. 1610759-22-2

CFI-402257 ( —— )

Catalog No. M27538 CAS No. 1610759-22-2

CFI-402257 is a orally active, and potent highly selective small-molecule inhibitor of Mps1 with Ki of 0.09 ± 0.02 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 446 Get Quote
10MG 550 Get Quote
25MG 878 Get Quote
50MG 1314 Get Quote
100MG 1773 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CFI-402257
  • Note
    Research use only, not for human use.
  • Brief Description
    CFI-402257 is a orally active, and potent highly selective small-molecule inhibitor of Mps1 with Ki of 0.09 ± 0.02 nM.
  • Description
    CFI-402257 is a orally active, and potent highly selective small-molecule inhibitor of Mps1 with Ki of 0.09 ± 0.02 nM.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1610759-22-2
  • Formula Weight
    498.6
  • Molecular Formula
    C28H30N6O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Poland T M , Groot P , Haack R A , et al. Evaluation of semiochemicals potentially synergistic to α-pinene for trapping the larger European pine shoot beetle, Tomicus piniperda (Col. Scolytidae)[J]. Journal of Applied Entomology, 2010, 128(9-10):639-644.
molnova catalog
related products
  • CDDO-2P-Im

    CDDO-2P-Im, an analog of CDDO-Imidazolide, has a chemopreventive effect. It can reduce the size and severity of the lung tumors in the mouse lung cancer model.

  • BC-1471

    BC-1471 is a novel selective antagonist of deubiquitinase STAM-binding protein (STAMBP), decreasing NALP7 protein levels and suppressing IL-1β release after TLR agonism.A small-molecule inhibitor of STAMBP deubiquitinase activity, BC-1471, decreases NALP7 protein levels and suppresses IL-1β release after TLR agonism.?

  • Quercetin 3-O-neohes...

    Quercetin 3-O-neohesperidoside shows anti-atherosclerosis, and antiplatelet aggregation activities.